D

DiogenX

10 employees

DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Biotechnology and Diabetes
Life Science

Date founded

2020

Funding rounds raised

Total raised

$30M

from 5 investors over 5 rounds

D

DiogenX raised $30M on May 10, 2023

Investors: AdBio partners, JDRF T1D Fund and Omnes

D

DiogenX raised $5.1M on June 16, 2020

Investors: AdBio partners and JDRF T1D Fund

FAQ